Replacement of EVOS imaging system
The National Institutes of Health (NIH) intends to award a non-competitive contract to Life Technologies Corporation for the replacement of an EVOS imaging system, which is critical for cancer cell research at the NIH/NCI in Bethesda, Maryland. The existing system is over 12 years old and experiencing reliability issues, requiring prompt replacement to prevent disruption to research programs. The procurement is conducted under simplified acquisition procedures and is not expected to exceed the simplified acquisition threshold of $350,000. Performance of services will take place at the NIH campus in Bethesda, Maryland. Interested parties must submit their responses by July 27, 2026, at 9:00 AM Eastern time.